A fractional CMO onboarding checklist helps a MedTech CEO turn an outside marketing leader into an effective part of the executive team. The essentials are straightforward: define the engagement’s scope and decision authority, share business and product goals, provide current performance data, introduce key stakeholders, and grant access to the systems needed to assess marketing.
Use the first 30, 60, and 90 days to move from diagnosis to priorities and execution. Agree on a small set of business-relevant measures, assign owners, document budget boundaries, and establish a regular decision and reporting cadence. The practical checklist below helps you reduce delays, surface gaps early, and evaluate progress without expecting a new fractional CMO to produce instant results.
What a Fractional CMO Should Own
A fractional chief marketing officer provides senior marketing leadership on a part-time or contract basis. The role may include market strategy, positioning, demand generation, team leadership, budgeting, measurement, and oversight of internal or external specialists. The exact responsibilities should be defined by the company’s needs rather than assumed from the title.
For a MedTech company, the role also requires disciplined coordination with product, sales, clinical, regulatory, legal, privacy, and security stakeholders when those functions are relevant. Marketing cannot operate as an isolated lead-generation department. Product claims, educational materials, customer communications, and campaign timing may require specialized review before publication or distribution.
The fractional CMO should not be treated as an agency account manager or a temporary campaign producer. The CEO is bringing in a leader to diagnose the marketing system, recommend priorities, coordinate resources, and connect marketing decisions with broader company objectives. Agencies and contractors may still execute the work, but the CMO should help determine what work matters, why it matters, who owns it, and how progress will be evaluated.
The Five-Part Fractional CMO Onboarding Checklist
Complete these five parts in sequence, but do not wait for every document to be perfect before beginning. Identify missing information, assign an owner, and keep the diagnostic work moving.
1. Define the Engagement Foundation
Start with a written charter. It should explain why the company is engaging a fractional CMO, what problems the role is expected to address, which decisions the CMO can make, and which decisions remain with the CEO or another executive. Define the expected time commitment, meeting obligations, deliverables, budget authority, reporting relationship, and process for changing the scope.
Clarify the boundary between leadership and execution. A fractional CMO may create the strategy and manage the people responsible for delivery, but the engagement may not include copywriting, design, media buying, marketing operations, or web development. List the internal employees, agencies, contractors, and technical resources available to implement the plan.
- Document the business problem and desired outcome.
- Define decision rights, approval thresholds, and budget limits.
- Assign an executive sponsor and an operational contact.
- Confirm confidentiality, security, data-access, and conflict requirements.
- Identify the people and resources available for execution.
Ask appropriate legal, regulatory, privacy, or security professionals to review engagement terms and access requirements when needed. The checklist is operational guidance, not legal or regulatory advice.
2. Provide Business, Market, and Product Immersion
Give the fractional CMO enough context to understand how the company creates value. Begin with the business model, revenue priorities, target markets, product portfolio, sales process, customer lifecycle, and major constraints. Explain which assumptions leadership considers settled and which remain open to challenge.
MedTech immersion should include more than a product demonstration. Explain the intended users, buyers, influencers, settings of use, purchasing process, implementation requirements, and common adoption barriers. Distinguish among the person who uses the product, the organization that purchases it, and any other stakeholder who affects the decision. If the company serves multiple segments, state which segment has priority and why.
Provide the current messaging architecture, approved product language, substantiation files where appropriate, brand standards, customer research, competitive analysis, and relevant product documentation. Identify which statements have already passed the company’s review process and which require further evaluation. Marketing should not infer clinical, safety, performance, or economic claims from informal conversations.
- Schedule interviews with the CEO and leaders from product, sales, customer success, finance, and operations.
- Include clinical, regulatory, legal, privacy, or security stakeholders when their review affects marketing.
- Share customer research, sales-call themes, objections, lost-opportunity notes, and implementation feedback.
- Explain upcoming launches, product changes, partnerships, and operational constraints.
- Identify approved terminology and the process for reviewing new materials.
3. Grant Controlled Access to Data, Systems, and People
A marketing leader cannot diagnose performance from slide decks alone. Provide access to the information needed to trace the path from market attention to qualified opportunity, sale, onboarding, adoption, and retention. This may include analytics, customer relationship management data, campaign reports, content inventories, budgets, pipeline reports, customer research, and vendor agreements.
Access should be deliberate. Use company-approved accounts, least-privilege permissions, multifactor authentication where required, and a documented process for changing or removing access. Avoid sending passwords through informal messages. Do not provide personal, patient, clinical, or other sensitive information merely because it might be useful. Involve the appropriate privacy, security, compliance, or legal professionals before granting access to protected or regulated data.
Create an access register with the system name, purpose, permission level, approver, owner, and status. If reliable data does not exist, say so. A known measurement gap is more useful than a polished report built on uncertain inputs.
Introduce the CMO directly to key employees and partners rather than relying on an organization chart. Each introduction should explain the person’s role, current priorities, connection to marketing, and any decisions the CMO will need from them.
4. Build the 30-60-90 Day Roadmap
The roadmap should turn the initial diagnosis into an ordered set of decisions and actions. It is a planning framework, not a promise that every company will reach the same milestone on the same date. Adjust it for the sales cycle, product maturity, data quality, review requirements, team capacity, and urgency of the business problem.
First 30 days: diagnose and align. Review the existing strategy, positioning, funnel, customer evidence, team capabilities, systems, budget, and active campaigns. Interview stakeholders and document gaps. Confirm the highest-priority business objective and present initial findings, risks, and decisions needed from leadership.
Days 31-60: set priorities and prepare execution. Convert findings into a focused marketing plan. Define target audiences, messaging priorities, channel roles, resource needs, measurement standards, and owners. Resolve approval bottlenecks before major work begins. Select a limited number of initiatives that the available team can execute well.
Days 61-90: begin execution and establish operating discipline. Launch approved priorities when the organization is ready, improve essential reporting, and document repeatable workflows. Review early signals without treating short-term activity as proof of business impact. Present what has been completed, what has been learned, which assumptions changed, and what the next planning period requires.
Every roadmap item should have an owner, due date, dependency, required decision, budget implication, and definition of completion. Separate controllable outputs, such as completing a messaging brief, from business outcomes, such as qualified pipeline. This prevents the team from confusing activity with results while recognizing that revenue outcomes may depend on factors outside marketing’s direct control.
5. Establish the Operating and Reporting Cadence
Agree on how decisions will be made after kickoff. A practical cadence often includes an operational marketing meeting, an executive decision meeting, and a written status update. The frequency should reflect the pace and scope of the work. A launch period may require more contact than a stable planning period.
Keep status reporting brief and decision-oriented. Report completed work, current measures, insights, blockers, upcoming priorities, resource needs, and decisions awaiting approval. Record decisions in a shared location so the team does not repeatedly reopen settled questions.
Define escalation rules as well. The fractional CMO should know whom to contact when a campaign raises a product-claim concern, sensitive data appears in a system, a budget exceeds its boundary, or teams disagree about a launch. Clear escalation paths protect momentum without bypassing necessary professional review.
How to Measure Early Progress
Early progress should be evaluated at three levels: diagnostic progress, operating progress, and business performance. The appropriate measures depend on the engagement and the reliability of the company’s data.
- Diagnostic progress: stakeholder interviews completed, data sources reviewed, customer journey documented, measurement gaps identified, and strategic recommendations delivered.
- Operating progress: priorities approved, owners assigned, decision rights clarified, review workflows documented, reporting established, and blockers resolved.
- Business performance: measures appropriate to the model, such as qualified opportunities, conversion through defined stages, sales-cycle movement, retention, product adoption, or marketing efficiency.
Do not fill the dashboard with every available metric. Choose a small set that helps leadership make decisions. Define each measure, its source, its owner, and any known limitations. If attribution is weak, distinguish observed results from assumptions. A credible baseline and a plan to improve measurement are meaningful early accomplishments.
Common Onboarding Mistakes
Leaving Authority Ambiguous
A CMO who can recommend but never obtain a decision becomes an expensive observer. Specify who approves strategy, messaging, spending, hiring, vendors, and launches. Set reasonable response expectations for decisions that could block the roadmap.
Hiding Weak or Incomplete Data
Incomplete data is common. Concealing its limitations is more damaging than acknowledging them. Tell the CMO which reports are trusted, where definitions differ, and which systems do not connect. Treat measurement repair as a prioritized workstream when it affects decisions.
Skipping Cross-Functional Introductions
Marketing plans often depend on sales, product, operations, finance, and specialized reviewers. Bring those people into onboarding early. Otherwise, the CMO may design work that cannot be approved, supported, measured, or implemented.
Expecting Immediate Revenue Results
Early onboarding should produce clarity, decisions, and a credible plan. The timing of revenue impact depends on the company’s starting point, sales cycle, resources, market conditions, data quality, and scope. Evaluate whether the CMO is improving the system while monitoring appropriate business signals.
Starting Too Many Initiatives
A long audit can create a long wish list. Require explicit prioritization. The roadmap should state what the team will do now, what it will defer, and what it will stop. Concentrated execution produces clearer learning than a collection of under-resourced projects.
Fractional CMO vs. Agency
A fractional CMO and an agency solve different problems, although their work can overlap. A fractional CMO generally provides embedded marketing leadership, helps set priorities, coordinates resources, and connects marketing with executive objectives. An agency generally delivers defined services or projects through an external team.
Choose based on the missing capability. If the company has specialists but lacks direction, prioritization, and executive marketing leadership, a fractional CMO may fit. If the strategy and internal ownership are clear but the company needs additional production or specialized execution, an agency may fit. Some companies use both, with the CMO directing strategy and the agency delivering agreed work.
Compare proposals by scope, authority, access, deliverables, execution capacity, communication model, and success measures. Fees alone do not reveal whether two providers are solving the same problem.
The CEO’s Role in a Successful Onboarding
The CEO does not need to manage the fractional CMO’s daily work, but the CEO must provide context, sponsorship, and timely decisions. Attend the kickoff, explain the company’s priorities and constraints, and make clear why the role matters. Publicly authorize the CMO to work across functions within the boundaries of the charter.
During roadmap reviews, ask about trade-offs, evidence, risks, dependencies, and resource requirements. Resolve conflicts among executives when competing goals stall execution. If the priorities change, update the roadmap instead of quietly adding work to the original scope.
Finally, evaluate the relationship itself. Ask whether the CMO is bringing clarity, making sound recommendations, communicating limitations, working constructively with the team, and improving accountability. The CMO should also be able to tell the CEO what support or decisions are missing.
Frequently Asked Questions
What should a CEO give a fractional CMO during onboarding?
Provide the engagement charter, business priorities, product and market context, team structure, current strategy, approved messaging, budgets, performance data, system access, active-project inventory, and stakeholder introductions. Identify missing or unreliable information instead of delaying onboarding until everything is complete.
How long should fractional CMO onboarding take?
A 30-60-90 day framework is useful for organizing diagnosis, planning, and initial execution, but it should not be treated as a universal performance guarantee. The pace depends on scope, access, data quality, internal capacity, review requirements, and the company’s sales cycle.
Which metrics should the CEO track first?
Start with measures tied to the engagement’s objective and the company’s business model. Track diagnostic and operating milestones alongside a limited number of business measures. Document definitions and data limitations so leadership does not make decisions from misleading comparisons.
What is different about onboarding a fractional CMO in MedTech?
The CMO may need deeper coordination with product, clinical, regulatory, legal, privacy, and security functions. The exact requirements vary by product, audience, jurisdiction, claims, and data involved. Establish the company’s review process and obtain appropriate professional guidance rather than assuming general marketing practices are sufficient.
Can a fractional CMO work with an existing agency?
Yes. The fractional CMO can help define strategy, priorities, budgets, performance measures, and agency briefs while the agency supplies agreed execution. Document responsibilities and approval paths so internal staff, the CMO, and the agency do not duplicate work.
Put the Checklist Into Action
Effective fractional CMO onboarding is an executive integration process, not a login handoff. Define the role, immerse the leader in the business, provide controlled access, build a realistic 30-60-90 day roadmap, and establish an operating cadence. When those five elements are clear, the CEO can evaluate the engagement through evidence, decisions, and accountable execution rather than activity alone.